These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 37356667)

  • 1. Reply to: RAAS inhibitors in COVID-19: Not all are created equal!
    Gonçalves J; Santos CD; Fresco P; Fernandez-Llimos F
    Rev Port Cardiol; 2023 Sep; 42(9):817-818. PubMed ID: 37356667
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one.
    Gonçalves J; Santos CD; Fresco P; Fernandez-Llimos F
    Rev Port Cardiol; 2024 Apr; 43(4):221-222. PubMed ID: 37918782
    [No Abstract]   [Full Text] [Related]  

  • 3. RAAS inhibitors in COVID-19: They are not all the same!
    Kow CS; Ramachandram DS; Hasan SS
    Rev Port Cardiol; 2023 Sep; 42(9):815-816. PubMed ID: 37353197
    [No Abstract]   [Full Text] [Related]  

  • 4. Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19.
    Kutz A; Conen A; Gregoriano C; Haubitz S; Koch D; Domenig O; Bernasconi L; Mueller B; Schuetz P
    Eur J Endocrinol; 2021 Apr; 184(4):543-552. PubMed ID: 33539316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19, hypertension, and RAAS blockers: the BRACE-CORONA trial.
    Mancia G
    Cardiovasc Res; 2020 Dec; 116(14):e198-e199. PubMed ID: 33245754
    [No Abstract]   [Full Text] [Related]  

  • 6. Renin-Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID-19.
    Loader J; Lampa E; Gustafsson S; Cars T; Sundström J
    J Am Heart Assoc; 2021 Aug; 10(15):e021154. PubMed ID: 34320843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review.
    Ingraham NE; Barakat AG; Reilkoff R; Bezdicek T; Schacker T; Chipman JG; Tignanelli CJ; Puskarich MA
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32341103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 and hypertension.
    Ravichandran B; Grimm D; Krüger M; Kopp S; Infanger M; Wehland M
    Physiol Rep; 2021 Jun; 9(11):e14800. PubMed ID: 34121359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What solid organ transplant healthcare providers should know about renin-angiotensin-aldosterone system inhibitors and COVID-19.
    Wong SY; Brubaker AL; Wang AX; Taiwo AA; Melcher ML
    Clin Transplant; 2020 Jul; 34(7):e13991. PubMed ID: 32446267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of blood pressure control and application of renin-angiotensin-aldosterone system inhibitors on the outcomes in COVID-19 patients with hypertension.
    Chen R; Yang J; Gao X; Ding X; Yang Y; Shen Y; He C; Xiang H; Ke J; Yuan F; Cheng R; Lv H; Li P; Zhang L; Liu C; Tan H; Huang L
    J Clin Hypertens (Greenwich); 2020 Nov; 22(11):1974-1983. PubMed ID: 33006442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one.
    Rothlin RP; Pelorosso F; Duarte M; Nicolosi L; Fernandez Criado I; Salgado MV; Vetulli H
    Rev Port Cardiol; 2024 Apr; 43(4):219-220. PubMed ID: 37940073
    [No Abstract]   [Full Text] [Related]  

  • 12. Is the prognosis of non-hypertensive, COVID-19 patients treated with renin-angiotensin-aldosterone system inhibitors more uncertain?
    García Martínez JJ; Wozniak H; Salamin P; Giraud R; Le Terrier C; Bendjelid K
    Physiol Rep; 2022 Nov; 10(22):e15512. PubMed ID: 36397298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAAS blockers in hypertension posing a higher risk toward the COVID-19.
    Singh Y; Gupta G; Satija S; Negi P; Chellappan DK; Dua K
    Dermatol Ther; 2020 Jul; 33(4):e13501. PubMed ID: 32359088
    [No Abstract]   [Full Text] [Related]  

  • 14. Renin-Angiotensin-Aldosterone Inhibitors and COVID-19 Infection.
    Tsampasian V; Corballis N; Vassiliou VS
    Curr Hypertens Rep; 2022 Oct; 24(10):425-433. PubMed ID: 35716247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renin-angiotensin-aldosterone system : brief history and questions related to the COVID-19 pandemic].
    Valdes-Socin H; Jouret F; Vroonen L; Scheen AJ; Lancellotti P
    Rev Med Liege; 2020 Sup; 75(S1):123-129. PubMed ID: 33211434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum ACE2, Angiotensin II, and Aldosterone Levels Are Unchanged in Patients With COVID-19.
    Rieder M; Wirth L; Pollmeier L; Jeserich M; Goller I; Baldus N; Schmid B; Busch HJ; Hofmann M; Kern W; Bode C; Duerschmied D; Lother A
    Am J Hypertens; 2021 Apr; 34(3):278-281. PubMed ID: 33043967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea.
    Son M; Seo J; Yang S
    Hypertension; 2020 Sep; 76(3):742-749. PubMed ID: 32654557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Interplay Between the Immune System, the Renin-Angiotensin-Aldosterone System (RAAS), and RAAS Inhibitors May Modulate the Outcome of COVID-19: A Systematic Review.
    Naveed H; Elshafeey A; Al-Ali D; Janjua E; Nauman A; Kawas H; Kaul R; Saed Aldien A; Elshazly MB; Zakaria D
    J Clin Pharmacol; 2021 Aug; 61(8):987-1000. PubMed ID: 33635546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
    Shukla AK; Banerjee M
    High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.